Apple Takes the Biggest Hit of the "Magnificent Seven" in Response to Trump Tariffs Tariffs will be the focus, but Apple's issues predate the shocking tariff announcement on April 2.
Why Tesla Stock Sank 11.5% in March Tesla stock is now down over 40% in 2025. Is it time to buy?
3 Under-the-Radar AI Stocks With Market-Beating Potential Innodata, Ambarella, and Symbotic could attract more attention soon.
Which S&P500 stocks are gapping on Monday? Let's have a look at what is happening on the US markets on Monday. Below you can find the S&P500 gap up and gap down stocks in today's session.
Major Equity Indices Deeply Oversold, But Widespread Selling Yet To Show Signs Of Letup Amid fears of tariffs-induced economic slowdown/contraction and indiscriminate selling of stocks, equity bulls are hoping for signs of stability and a relief rally.
Monday's session: gap up and gap down stocks Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Rhythm Pharmaceuticals Weight Loss Drug Study Shows Significant BMI Reduction For Rare Type Of Obesity Disorder Rhythm's Phase 3 trial shows setmelanotide significantly reduced BMI in rare hypothalamic obesity without new safety concerns over 52 weeks.
Palantir Stock Rises Defying Market Downturn: Retail Shrugs Off Upside As ‘Dead-Cat Bounce’ The Department of Defense’s move to cut costs exerted downward pressure on Palantir stock even before President Donald Trump’s tariffs hit the market hard.
Nvidia, Apple Top 'Names To Own': Cybersecurity Stocks To Outperform, Tech Analyst Dan Ives Says Investors may find safe havens with the tech industry as the market volatility continues under the uncertainty of Trump's tariff policies.
Bitcoin Whipsaws As Trillions In Market Value Are Erased On Fake Tariff Pause Rumor A false report claiming the Trump administration was preparing a 90-day pause on tariffs triggered a wave of volatility across U.S. equity and crypto markets on Monday.
Vertex's Journavx Launch Sparks Optimism, Analyst Sees 'Two Potential Upside Levers' Vertex Pharmaceuticals sees early success with Journavx painkiller, potential revenue growth from drug and gene therapy.
Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years Anavex's blarcamesine shows sustained cognitive and functional benefit in early Alzheimer's patients after four years of continuous treatment.
Trump's Trade War Gets EU Ready To Negotiate On Tariffs – ‘We Have Offered Zero-For-Zero Tariffs For Industrial Goods…’ European Commission President Ursula von der Leyen indicated that the bloc prefers talking it out with the Trump administration to resolve the tariff war but also noted that it is preparing countermeasures.
Why Is XRP Down Today? Trump's Trade War Triggers Sell-Off As Price Hits Five-Month Low XRP (CRYPTO: XRP) plunged to $1.65 on Monday, its lowest price since November of last year, as investors fled crypto markets amid escalating global trade tensions sparked by U.S.
Why Is Bitcoin Down Today? Trump Tariffs Spark Market Panic as BTC Slides Below $75K Bitcoin plunged below $75,000 as Trump's global tariffs spark mass sell-off. Here's why BTC is down today and what analysts expect next.
Penguin Delivers Big Quarter, Yet JPMorgan Sees Momentum Fading In Second Half Penguin Solutions Inc (
NASDAQ: PENG ) shares tanked despite strong Q2 results and raised revenue guidance, with JP Morgan maintaining a Neutral rating.
